Carteolol (ophthalmic) vs Phosphodiesterase 5 Inhibitors

Interacting Drugs
Carteolol (ophthalmic)
vs
Phosphodiesterase 5 Inhibitors
Security Level
Minor, Monitor Therapy
Mechanism
Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Carteolol (ophthalmic) vs Phosphodiesterase 5 Inhibitors


Other Interactions of Carteolol (ophthalmic)

We are Developing Our database, More results coming soon.

Other Interactions of Phosphodiesterase 5 Inhibitors

We are Developing Our database, More results coming soon.